Zimmer Biomet Holdings, Inc. (ZBH) analyst actions
Rating and price-target actions on ZBH in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ZBH overview →
1 measured ZBH analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zimmer Biomet Holdings, Inc. (ZBH) And Encourages Stockholders to Reach Out | Press release | -0.33% | +0.77% |
Keep exploring
More ZBH: earnings → · SEC filings → · ZBH overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MYOKARDIA (MYOK) | 635 | -0.01% | 45% |
| Novan, Inc. (NOVN) | 634 | -0.02% | 45% |
| Incyte Corporation (INCY) | 633 | +0.05% | 53% |
| BIOSPECIFICS TECHNOLOGIES (BSTC) | 632 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.